Menu

 

Research News

Who needs β blockers?

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e6612 (Published 3 October 2012)
Cite this as: BMJ 2012;345:e6612

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

JAMA2012;308:1340-9OpenUrlCrossRef

β blockers are recommended for heart failure and for secondary prevention after a recent myocardial infarction (MI). Doctors should think twice before prescribing these drugs to other high risk …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls